Skip to main content
. 2017 Aug 10;40(8):550–557. doi: 10.14348/molcells.2017.0019

Fig. 3.

Fig. 3

Relative mRNA expressions of representative markers involved in teno/ligamentogenic differentiation of hPDLSCs co-treated with FGF-2 and TGF-β1.

Cells were treated with TGF-β1 (5 ng/ml) for 2 days, followed by treatment with FGF-2 (5 and 100ng/ml) for 5 days. (a), tenomodulin; (b), scleraxis. Significant differences from statistical analysis were indicated as *P < 0.01. **P < 0.05, and ***P < 0.1.